Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Start Date
2/1/2021
Completion Date
3/1/2031
Summary
ARB-PMCF is a multicenter, observational study of the safety and performance of Abbott annuloplasty devices used in surgical repair of mitral and tricuspid valve regurgitation. The devices included in this study are the SJM™ Rigid Saddle Ring and SJM Séguin Annuloplasty Ring, indicated for mitral valve repair, and the SJM Tailor™ Annuloplasty Ring and SJM Tailor Annuloplasty Band, indicated for mitral or tricuspid repair. Participants will be enrolled prior to undergoing mitral or tricuspid valve repair surgery including an Abbott annuloplasty implant and will complete annual follow-up visits through five years from implant. The study is being conducted to meet post-market clinical follow-up requirements of the European Union Medical Device Directives.
Detailed Description
The ARB-PMCF Study has a prospective, multicenter, observational, parallel group design in which up to 550 subjects will be followed through five years from implant of an Abbott annuloplasty device, with or without concomitant procedures, in five treatment groups, including primary mitral disease repair (N=200) with the Rigid Saddle Ring, Séguin Ring or full Tailor Ring without cut zone removal; secondary mitral disease repair (N=200) with the Rigid Saddle Ring, Séguin Ring or full Tailor Ring; primary tricuspid disease repair with the full Tailor Ring (N=50); secondary tricuspid disease repair with the full Tailor Ring (N=50); and primary tricuspid disease repair with the Tailor Band or partial Tailor Ring with cut zone removed (N=50). Study enrollment will occur at up to 25 global centers with approximately half or more of all implanted subjects being from European sites. The study will enroll adult subjects expected to be implanted with an Abbott annuloplasty device within 90 days who meet all other eligibility requirements. Participants will complete annual in-clinic or telephone follow-up visits through five years from their annuloplasty implant. Data collected will include adverse events, cardiac medication usage, New York Heart Association functional classification (a measure of the severity of heart failure symptoms) and echocardiographic assessments of regurgitation through the repaired valve.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Abbott SJM Rigid Saddle Ring
Abbott SJM Séguin Ring
Abbott SJM Tailor Ring
Abbott SJM Tailor Band
Conditions
Locations
Duke University Hospital
Durham, North Carolina 27710
United States
University of Wisconsin Hospital and Clinics
Madison, Wisconsin 53792
United States
Tartu University Hospital
Tartu, 50406
Estonia
Hopital Cardiovasculaire et Pneumologique Louis Pradel
Lyon, Auvergne-Rhône-Alpes 69500
France
CHU de Besançon - Jean Minjoz
Besançon, Bourgogne-Franche-Comté 25000
France
Herzchirurgische Abteilung Klinikum Passau
Passau, Bavaria 94032
Germany
Universitätsklinikum Würzburg
Würzburg, Bavaria 97080
Germany
Herzzentrum-Bremen Klinikum Links der Weser
Bremen, Free Hanseatic City of Bremen 28211
Germany
Herzzentrum Dresden, Universitätsklinik an der Technischen Universität Dresden
Dresden, Saxony 01307
Germany
Universitätsklinikum Jena
Jena, Thuringia 07740
Germany
Policlinico S.Orsola-Malpighi
Bologna, Bologna 40138
Italy
Ospedale San Raffaele - Cardiac
Milan, Lombardy 1350
Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Lombard 20157
Italy
Ospedale Luigi Sacco
Milan, Milan 20157
Italy
Ospedale Umberto I
Turin, Piedmont 10128
Italy
Catharina Ziekenhuis
Eindhoven, North Brabant 5623 EJ
Netherlands
Hospital Alvaro Cunqueiro
Vigo, Pontevedra 36312
Spain